| Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective … JE Thompson, D Moses, R Shnier, P Brenner, W Delprado, L Ponsky, ... The Journal of urology 192 (1), 67-74, 2014 | 272 | 2014 |
| The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the … L Emmett, J Buteau, N Papa, D Moon, J Thompson, MJ Roberts, K Rasiah, ... European urology 80 (6), 682-689, 2021 | 239 | 2021 |
| Superior quality of life and improved surgical margins are achievable with robotic radical prostatectomy after a long learning curve: a prospective single-surgeon study of 1552 … JE Thompson, S Egger, M Böhm, AM Haynes, J Matthews, K Rasiah, ... European urology 65 (3), 521-531, 2014 | 194 | 2014 |
| The role of magnetic resonance imaging in the diagnosis and management of prostate cancer J Thompson, N Lawrentschuk, M Frydenberg, L Thompson, P Stricker, ... BJU international 112, 6-20, 2013 | 194 | 2013 |
| The diagnostic performance of multiparametric magnetic resonance imaging to detect significant prostate cancer JE Thompson, PJ Van Leeuwen, D Moses, R Shnier, P Brenner, ... The Journal of urology 195 (5), 1428-1435, 2016 | 178 | 2016 |
| Using the ISBAR handover tool in junior medical officer handover: a study in an Australian tertiary hospital JE Thompson, LW Collett, MJ Langbart, NJ Purcell, SM Boyd, ... Postgraduate medical journal 87 (1027), 340-344, 2011 | 163 | 2011 |
| Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis B Pang, Y Zhu, J Ni, J Thompson, D Malouf, J Bucci, P Graham, Y Li Theranostics 10 (5), 2309, 2020 | 156 | 2020 |
| Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: preliminary findings from a multiinstitutional study SB Ginsburg, A Algohary, S Pahwa, V Gulani, L Ponsky, HJ Aronen, ... Journal of Magnetic Resonance Imaging 46 (1), 184-193, 2017 | 142 | 2017 |
| A multiparametric magnetic resonance imagingbased risk model to determine the risk of significant prostate cancer prior to biopsy PJ van Leeuwen, A Hayen, JE Thompson, D Moses, R Shnier, M Böhm, ... BJU international 120 (6), 774-781, 2017 | 126 | 2017 |
| Radiomic features on MRI enable risk categorization of prostate cancer patients on active surveillance: Preliminary findings A Algohary, S Viswanath, R Shiradkar, S Ghose, S Pahwa, D Moses, ... Journal of Magnetic Resonance Imaging 48 (3), 818-828, 2018 | 120 | 2018 |
| Diagnostic accuracy of 68Gaprostatespecific membrane antigen (PSMA) positronemission tomography (PET) and multiparametric (mp)MRI to detect intermediategrade … MJ Scheltema, JI Chang, PD Stricker, PJ van Leeuwen, QA Nguyen, B Ho, ... BJU international 124, 42-49, 2019 | 100 | 2019 |
| Focal irreversible electroporation as primary treatment for localized prostate cancer W van den Bos, MJ Scheltema, AR Siriwardana, AMF Kalsbeek, ... BJU international 121 (5), 716-724, 2018 | 98 | 2018 |
| Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer J Wang, J Ni, J Beretov, J Thompson, P Graham, Y Li Critical reviews in oncology/hematology 145, 102860, 2020 | 90 | 2020 |
| Superior biochemical recurrence and long-term quality-of-life outcomes are achievable with robotic radical prostatectomy after a long learning curve—updated analysis of a … JE Thompson, S Egger, M Böhm, AR Siriwardana, AM Haynes, ... European urology 73 (5), 664-671, 2018 | 73 | 2018 |
| Oncological and quality-of-life outcomes following focal irreversible electroporation as primary treatment for localised prostate cancer: a biopsy-monitored prospective cohort A Blazevski, MJ Scheltema, B Yuen, N Masand, TV Nguyen, W Delprado, ... European urology oncology 3 (3), 283-290, 2020 | 72 | 2020 |
| Initial multicentre experience of 68galliumPSMA PET/CT guided robotassisted salvage lymphadenectomy: acceptable safety profile but oncological benefit … A Siriwardana, J Thompson, PJ van Leeuwen, S Doig, A Kalsbeek, ... BJU international 120 (5), 673-681, 2017 | 72 | 2017 |
| The PRIMARY score: using intraprostatic 68Ga-PSMA PET/CT patterns to optimize prostate cancer diagnosis L Emmett, N Papa, J Buteau, B Ho, V Liu, M Roberts, J Thompson, ... Journal of Nuclear Medicine 63 (11), 1644-1650, 2022 | 67 | 2022 |
| Combination of peri-tumoral and intra-tumoral radiomic features on bi-parametric MRI accurately stratifies prostate cancer risk: a multi-site study A Algohary, R Shiradkar, S Pahwa, A Purysko, S Verma, D Moses, ... Cancers 12 (8), 2200, 2020 | 65 | 2020 |
| Learning curves for robotic surgery: a review of the recent literature G Mazzon, A Sridhar, G Busuttil, J Thompson, S Nathan, T Briggs, J Kelly, ... Current Urology Reports 18, 1-6, 2017 | 62 | 2017 |
| Protocol for the PRIMARY clinical trial, a prospective, multicentre, crosssectional study of the additive diagnostic value of gallium68 prostatespecific membrane antigen … A Amin, A Blazevski, J Thompson, MJ Scheltema, MS Hofman, D Murphy, ... BJU international 125 (4), 515-524, 2020 | 61 | 2020 |
PHILLIP STRICKERSt Vincents Hospital Sydney在 stricker.com.au 的电子邮件经过验证
